Jukka Perttu

Jukka Perttu is a journalist for Helsingin Sanomat in Finland. He is currently an Innovation Journalism Fellow at Stanford University and is working for Xconomy during his fellowship.

Recent posts

QinetiQ, Thermo Scientific Collaborate to Equip Explosive-Sniffing Robots with Smart Sensors
Chemically fueled improvised explosive devices (IEDs) are one of the deadliest hazards to soldiers in Iraq and Afghanistan, and incidents like the Oklahoma City bombing and the Sarin gas attack in... Read more »
MIT Spinoff Levant Power On Track to Produce Energy-Boosting Shock Absorbers For Cars, Tanks, and Trains
With gasoline prices on the rise and carbon dioxide emissions threatening to bring about global climate disaster, MIT spinoff startup Levant Power is trying to help drivers cut fuel consumption—by turning... Read more »
Pietzo’s Bikes Electrify Massachusetts Commuters
Millions of commuters suffer daily in traffic jams. Cars burn expensive, non-renewable gasoline and pollute our air while producing tons of carbon dioxide that threaten to bring about disastrous global climate... Read more »
QD Vision’s Quantum Dots Warm Up the Market for LED Lighting
Everyone knows that traditional incandescent lamps are inefficient and energy-wasting. But LEDs, one of the technologies vying to take their place, produce light that feels harsh and cold by comparison, leading... Read more »
Terrafugia Says Flying Car Likely to Take Off in Massachusetts, But Might Land Elsewhere
Terrafugia, the Woburn, MA-based company out to produce the first practical flying car—or street legal airplane, to use the company’s term— said today it plans to build its first commercial vehicle... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Invetx Fetches $15M to Develop Biologic Drugs for Man’s Best Friend

BioIntelliSense Debuts "Sticker” Sensor to Capture Patient Data Remotely

Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential

Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug

SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

Quench Bio Springs From Atlas With $50M for a New Take on Inflammation

Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto

Xcelerating Life Sciences San Diego

Xcelerating Life Sciences Boston

Xcelerating Life Sciences Philadelphia

Jukka Perttu

Recent posts

QinetiQ, Thermo Scientific Collaborate to Equip Explosive-Sniffing Robots with Smart Sensors

MIT Spinoff Levant Power On Track to Produce Energy-Boosting Shock Absorbers For Cars, Tanks, and Trains

Pietzo’s Bikes Electrify Massachusetts Commuters

QD Vision’s Quantum Dots Warm Up the Market for LED Lighting

Terrafugia Says Flying Car Likely to Take Off in Massachusetts, But Might Land Elsewhere

Underwriters and Partners

How to Approach Life Sciences Fundraising

What’s Next in Neuroscience Therapies

Potency Assay Development for Cell and Gene Therapy Products

Xconomy on Demand

We offer a number of ways to subscribe for free!